Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs ; volume:31 ; number:7 ; day:12 ; month:6 ; year:2017 ; pages:585-602 ; date:7.2017
CNS drugs ; 31, Heft 7 (12.6.2017), 585-602, 7.2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Jongen, Peter Joseph
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-017-0444-x
- URN
-
urn:nbn:de:1111-201708035488
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jongen, Peter Joseph
- SpringerLink (Online service)
Other Objects (12)
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies